Thromboangitis obliterans is associated with ?

Correct Answer: HLA - B5
Description: Ans. is 'c' i.e., HLA - B5 Thromboangitis obliterans (Berger disease) Thrombangitis obliterans is a distinctive disease that is characterized by segmental, thrombosing acute and chronic inflammation of medium sized and small sized aeries, and sometimes secondarily extending to veins and nerves. Thromboangitis obliterans occurs almost exclusively among heavy-cigarrete-smoking persons. It is more common in men but incidence is increasing in women because of increasing smoking habit in women. o Buerger disease is associated with HLA B-5 and HLA-A9. In thrombongitis obliterans there is acute and chronic segmental inflammation of vessels with accompanied thrombosis in the lumen. Typically, the thrombus contains microabscesses with a central focus of neutrophils surrounded by gran u lomatous inflammation. Later, the inflammatory process extends into contiguous veins and nerves and in time all three structures (aeries, veins and nerves) become encased in fibrous tissue, a characterstic that is very rare with other form of vasculitis. Clinical manifestations Thrombangitis obliterans affects vessels of upper and lower extremities. Symptoms are due to vascular insufficiency, i.e. Ischemia of toes, feet and fingers that can lead to ulcer and frank gangrene. Due to neural involvement, there may be severe pain, even at rest.
Category: Pathology
Share:

Get More
Subject Mock Tests

Practice with over 200,000 questions from various medical subjects and improve your knowledge.

Attempt a mock test now
Mock Exam

Take an exam with 100 random questions selected from all subjects to test your knowledge.

Coming Soon
Get More
Subject Mock Tests

Try practicing mock tests with over 200,000 questions from various medical subjects.

Attempt a mock test now
Mock Exam

Attempt an exam of 100 questions randomly chosen from all subjects.

Coming Soon
WordPress › Error

There has been a critical error on this website.

Learn more about troubleshooting WordPress.